Table 6. The example of a score based decision approach in a chronic myeloid leukemia patient after the acute toxic imatinib-induced liver injury (imatinib withdrawal).
Factors | Imatinib restart* |
The grade of hepatotoxicity reaction | |
I grade | |
II grade | |
III grade | |
IV grade / the presence of the liver transplantation or imatinib-induced liver cirrhosis caused by drug interaction or viral hepatitis reactivation | 0 |
The presence of EMR to the imatinib therapy defined as three-month BCR-ABL1IS ≤10%: | |
Yes | |
No | 0 |
The presence of EMR to the imatinib therapy defined as six-month BCR-ABL1IS <1% (if applicable****): | N/A |
Yes | |
No | |
The presence of the offender concomitant drug probably caused drug interaction | |
Yes | |
No | 0 |
The presence of the viral hepatitis reactivation identified by Polymerase Chain Reaction (PCR+) | |
Yes | |
No | 0 |